Dr. Christopher Obeime, MD

NPI: 1659480697
Total Payments
$911,807
2024 Payments
$204,199
Companies
43
Transactions
2,265
Medicare Patients
2,983
Medicare Billing
$279,987

Payment Breakdown by Category

Other$732,216 (80.3%)
Consulting$65,093 (7.1%)
Food & Beverage$60,082 (6.6%)
Travel$53,436 (5.9%)
Education$979.54 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $716,109 261 78.5%
Consulting Fee $65,093 31 7.1%
Food and Beverage $60,082 1,698 6.6%
Travel and Lodging $53,436 219 5.9%
Honoraria $16,107 9 1.8%
Education $979.54 47 0.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $550,088 640 $0 (2024)
Galderma Laboratories, L.P. $125,265 242 $0 (2024)
UCB, Inc. $32,908 85 $0 (2024)
Dermavant Sciences, Inc. $32,891 81 $0 (2024)
Regeneron Healthcare Solutions, Inc. $22,204 73 $0 (2024)
Incyte Corporation $21,010 53 $0 (2024)
PFIZER INC. $15,589 145 $0 (2024)
DERMIRA, INC. $15,341 22 $0 (2020)
Allergan Inc. $13,918 33 $0 (2017)
Promius Pharma LLC $13,724 44 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $204,199 378 ABBVIE INC. ($118,640)
2023 $182,420 333 ABBVIE INC. ($99,095)
2022 $148,537 292 ABBVIE INC. ($115,457)
2021 $27,050 171 AbbVie Inc. ($16,189)
2020 $31,964 124 AbbVie Inc. ($15,872)
2019 $101,337 269 AbbVie, Inc. ($56,788)
2018 $106,273 363 AbbVie, Inc. ($66,244)
2017 $110,027 335 AbbVie, Inc. ($61,803)

All Payment Transactions

2,265 individual payment records from CMS Open Payments — Page 1 of 91

Date Company Product Nature Form Amount Type
12/26/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $800.00 General
12/23/2024 PFIZER INC. CIBINQO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,950.00 General
Category: Inflammation & Immunology
12/18/2024 Ortho Dermatologics, a division of Bausch Health US, LLC Cabtreo (Drug) Food and Beverage In-kind items and services $23.64 General
Category: Dermatology
12/17/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,600.00 General
Category: IMMUNOLOGY
12/17/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Winlevi (Drug) Food and Beverage In-kind items and services $18.01 General
Category: Dermatology
12/17/2024 PFIZER INC. CIBINQO (Drug), LITFULO Food and Beverage In-kind items and services $11.38 General
Category: Inflammation & Immunology
12/16/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $17.86 General
Category: Immunology
12/16/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $6.47 General
12/13/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $17.79 General
Category: DERMATOLOGY
12/11/2024 Almirall LLC Klisyri (Drug) Food and Beverage In-kind items and services $25.63 General
Category: Dermatology
12/10/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $3,200.00 General
Category: IMMUNOLOGY
12/10/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $21.82 General
Category: IMMUNOLOGY
12/10/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $17.07 General
Category: INFLAMMATION AND IMMUNOLOGY
12/10/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $15.34 General
Category: Immunology
12/09/2024 PFIZER INC. EUCRISA (Drug), CIBINQO, LITFULO Food and Beverage In-kind items and services $10.58 General
Category: DERMATOLOGY
12/06/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $5.73 General
12/05/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $12.81 General
Category: Immunology
12/05/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $2.32 General
Category: Immunology
12/04/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $20.14 General
Category: IMMUNOLOGY
12/03/2024 PFIZER INC. CIBINQO (Drug) Food and Beverage In-kind items and services $70.22 General
Category: Inflammation & Immunology
12/02/2024 PFIZER INC. EUCRISA (Drug), CIBINQO, LITFULO Food and Beverage In-kind items and services $11.32 General
Category: DERMATOLOGY
11/26/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $9.69 General
Category: Dermatology
11/21/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $14.66 General
Category: Immunology
11/20/2024 ABBVIE INC. RINVOQ (Biological) Travel and Lodging In-kind items and services $1,031.15 General
Category: IMMUNOLOGY
11/20/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $120.01 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 640 999 $192,140 $70,671
2022 9 757 1,077 $201,715 $76,525
2021 12 845 1,360 $195,339 $78,619
2020 13 741 1,184 $154,058 $54,172
Total Patients
2,983
Total Services
4,620
Medicare Billing
$279,987
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 174 250 $42,500 $19,461 45.8%
17004 Destruction of precancer skin growth, 15 or more growths Office 2023 82 126 $47,250 $13,566 28.7%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2023 100 253 $44,275 $12,995 29.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 109 109 $20,710 $11,556 55.8%
11102 Biopsy of related skin growth, first growth Office 2023 94 114 $19,950 $7,202 36.1%
11103 Biopsy of related skin growth, each additional growth Office 2023 52 114 $13,680 $3,949 28.9%
11104 Punch biopsy, first skin growth Office 2023 11 13 $2,275 $1,146 50.4%
11900 Injection into skin growth, 1-7 growths Office 2023 18 20 $1,500 $796.36 53.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 176 263 $43,650 $21,150 48.5%
17004 Destruction of precancer skin growth, 15 or more growths Office 2022 90 123 $46,125 $13,788 29.9%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2022 124 245 $42,875 $12,956 30.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 105 105 $19,520 $10,859 55.6%
11102 Biopsy of related skin growth, first growth Office 2022 122 142 $24,850 $9,699 39.0%
11103 Biopsy of related skin growth, each additional growth Office 2022 59 102 $12,240 $3,691 30.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 50 54 $8,130 $2,248 27.6%
11900 Injection into skin growth, 1-7 growths Office 2022 20 32 $2,400 $1,097 45.7%
11104 Punch biopsy, first skin growth Office 2022 11 11 $1,925 $1,037 53.9%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2021 113 272 $47,600 $14,459 30.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 129 163 $22,005 $13,338 60.6%
17004 Destruction of 15 or more premalignant skin growths Office 2021 68 104 $39,000 $12,073 31.0%
11102 Tangential biopsy of single skin lesion Office 2021 113 138 $24,150 $9,495 39.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 138 180 $21,630 $9,149 42.3%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 61 61 $10,675 $6,396 59.9%
11103 Tangential biopsy of additional skin lesion Office 2021 64 123 $12,300 $4,602 37.4%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 61 61 $7,625 $3,966 52.0%

About Dr. Christopher Obeime, MD

Dr. Christopher Obeime, MD is a Specialist healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659480697.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Obeime, MD has received a total of $911,807 in payments from pharmaceutical and medical device companies, with $204,199 received in 2024. These payments were reported across 2,265 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($716,109).

As a Medicare-enrolled provider, Obeime has provided services to 2,983 Medicare beneficiaries, totaling 4,620 services with total Medicare billing of $279,987. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Dermatology
  • Location Indianapolis, IN
  • Active Since 08/30/2006
  • Last Updated 07/01/2022
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1659480697

Products in Payments

  • RINVOQ (Biological) $230,530
  • Humira (Biological) $108,903
  • SKYRIZI (Biological) $108,538
  • AKLIEF (Drug) $69,197
  • Skyrizi (Biological) $34,870
  • VTAMA (Drug) $32,891
  • EPIDUO FORTE (Drug) $29,708
  • Bimzelx (Biological) $29,633
  • HUMIRA (Biological) $22,159
  • OPZELURA (Drug) $18,757
  • DUPIXENT DUPILUMAB INJECTION (Biological) $16,749
  • QBREXZA (Drug) $15,162
  • CIBINQO (Drug) $12,977
  • Promiseb Complete (Device) $6,490
  • Seysara (Drug) $6,145
  • ACZONE (Drug) $6,089
  • TWYNEO (Drug) $5,981
  • DUPIXENT (Biological) $5,609
  • SEYSARA (Drug) $5,391
  • DUPIXENT (Drug) $5,083

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Indianapolis